Table 5.
Indication versus antidepressant classes.
| Indication | Antidepressant classes | |||
|---|---|---|---|---|
|
SSRI
N (%) |
TCA
N (%) |
SNRI
N (%) |
AD directly affecting NR
N (%) |
|
| Depression | 15 (83.3) | 7 (46.7) | 7 (63.6) | 11 (40.7) |
| Anxiety and panic disorder | 0 (0) | 1 (6.7) | 1 (9.1) | 0 (0) |
| Neuropathic pain | 0 (0) | 4 (26.7) | 1 (9.1) | 0 (0) |
| Behavioral disorders in dementia | 0 (0) | 0 (0) | 0 (0) | 6 (22) |
| Migraine | 0 (0) | 0 (0) | 0 (0) | 1 (3.7) |
| Sleeping disorders | 0 (0) | 0 (0) | 0 (0) | 9 (33.3) |
| Others | 0 (0) | 2 (13.3) | 0 (0) | 0 (0) |
| No indication | 3 (16.7) | 1 (6.7) | 2 (18.2) | 0 (0) |
p < 0.001, Fisher Freeman Halton test.
AD, antidepressant; NR, neurotransmitter; SNRI, serotonin and noradrenalin reuptake inhibitor; SSRI, selective serotonin reuptake inhibitor; TCA, tricyclic antidepressant.